Industry News

160
FTMO is proud to announce a groundbreaking partnership with DXtrade, setting a new standard for our trading community. ...
130
The Trading Pit is thrilled to announce a revolutionary update that’s set to transform your trading journey: The ...
122
MyFundedFX is thrilled to announce an upcoming integration with Blueberry Markets, marking a significant milestone in our journey. ...
259
As we approach the end of Daylight Saving Time in North America on March 5, 2024, FTMO is ...
136
Big news from FunderPro – we’re excited to announce our brand-new $150k Challenge, designed to cater to the ...
119
As the year draws to a close, FundedNext is giving traders the opportunity to finish strong with the ...
132
The Trading Pit is excited to announce the addition of Skrill and NETELLER to our payment options, offering ...
143
FTUK is thrilled to announce a limited-time special offer designed to supercharge your trading journey. We’re now offering ...
218
FundYourFX proudly presents its latest breakthrough in trading technology – the new FundYourFX Dashboard. This advanced interface is ...
167
The Funded Trader stands at the forefront of simulated trading excellence, having been crowned the “Best Prop Simulated ...

New Prop Firms

iFunds, established in March 2024, is a proprietary trading firm offering instant funding accounts ranging from $2,500 to $500,000 without requiring traders to complete evaluations or demo challenges. It stands out for its flexible trading conditions, including no daily drawdown limits, customizable profit splits, and rapid withdrawals. While appealing to experienced traders, its premium fees and limited operational history may require cautious consideration before investment.

DNA Funded is a broker-backed prop trading firm that aims to help traders get simulated funded capital up to $600,000. They offer flexible challenge options, plus boosters to fast-track evaluations. With access to major markets, including forex and crypto, the platform is designed for those seeking bigger opportunities under clearly stated risk parameters. Whether you’re a newbie or a seasoned pro, DNA Funded aims to be your stepping stone into advanced prop trading.

Blueberry Funded, established in 2024, operates as a prop trading firm within the Blueberry family of brands, which also includes Blueberry Markets and Blueberry Partners.

Prop Number One is a global prop trading platform offering traders transparent rules, competitive payouts, and flexible account options to optimize their trading experience.

TradeApp is a new prop trading firm offering global traders access to capital with flexible evaluation phases, profit splits of up to 90%, and educational resources. Ideal for traders looking to grow without risking personal funds.

We Fund You Trade (WFYT) offers traders a chance to manage up to $200,000 in capital with profit splits of up to 85%. Their two-step evaluation process aims to identify disciplined and profitable traders, providing a clear pathway to funded trading.

The information provided on All Prop Trading Firms is for informational purposes only. We aim to provide comprehensive and unbiased reviews of various prop trading firms along with sharing valuable discount coupons and updates. However, we do not take responsibility for any decisions made based on the information presented on our site. Trading involves substantial risks and is not suitable for every investor. We highly recommend that you read the terms and conditions of each prop firm and conduct thorough research before engaging in any trading activities.
At All Prop Trading Firms, we believe in transparency and building trust with our audience. We would like to inform you that we have affiliate relationships with some of the prop firms listed on our site. This means that we may receive compensation if you click on affiliate links and make a purchase through these links. Please note that this does not incur any additional cost to you as a buyer. Our affiliate partnerships help us sustain our site and continue to provide valuable content to our readers.